The GLP-1 and Gym Performance Study: What Happened When Researchers Tracked Men's Workouts
One of the most talked-about findings from ENDO 2026 wasn't about hormones or metabolism — it was about steps. A study using Fitbit data found that GLP-1 users walked an average of 560 fewer steps per day after starting medication. Headlines ran with the implication that GLP-1s make you less active. The reality is more nuanced, and for men who train intentionally, arguably irrelevant.
The 560-Step Finding: Context Matters
The Fitbit study measured total daily step count — not structured exercise. It captured all movement: walking to your car, pacing during phone calls, running errands, and everything else that constitutes non-exercise activity thermogenesis (NEAT). When you're eating significantly less, your body naturally conserves energy by reducing unconscious movement. This is a documented metabolic response to caloric deficit, not a unique GLP-1 side effect.
What the study did not show: that men who intentionally exercise reduce their training volume or intensity on GLP-1 therapy. Structured exercise and NEAT are different systems, and they respond differently to energy availability.
The distinction that matters: Unconscious daily movement (NEAT) decreases modestly on GLP-1 therapy — this is your body conserving energy during caloric deficit. Intentional exercise performance is largely maintained when men continue their training programs. The 560-step decline is background activity, not gym performance.
What Gym Performance Actually Looks Like
Clinical observations and emerging research on resistance training during GLP-1 therapy paint a consistent picture:
Absolute strength may decrease modestly. If you lose 30 pounds, your squat and deadlift numbers may drop 5-10% — because you're literally carrying less weight through your daily life and your muscles adapt accordingly. This is normal during any significant weight loss.
Relative strength typically increases. Your strength-to-bodyweight ratio — a better measure of functional fitness — almost always improves. A man who squats 225 at 250 pounds and then squats 210 at 215 pounds has gotten meaningfully stronger in relative terms.
Endurance improves. Cardiovascular exercise becomes easier as body weight decreases. Running pace improves, cycling gets faster, and recovery between sets shortens. Men consistently report better conditioning even as caloric intake is lower.
| Performance Metric | Typical Change | Why |
|---|---|---|
| Absolute 1RM lifts | Down 5-10% | Reduced body mass and caloric intake |
| Relative strength (strength/BW) | Up 10-15% | Muscle preserved while weight drops |
| Running pace (per mile) | Faster by 30-90 sec | Less weight to move per stride |
| Recovery between sets | Improved | Better cardiovascular efficiency |
| Workout duration tolerance | May decrease initially | Lower energy availability in first weeks |
Adapting Your Training
Don't cut volume, adjust expectations. Keep your training program structure the same — exercises, sets, frequency. If you need to reduce weight on certain lifts, do so, but maintain the volume (total sets × reps). Volume is the primary driver of muscle retention during caloric deficit.
Prioritize compound movements. Squats, deadlifts, bench press, overhead press, and rows give you the most muscle-preservation stimulus per minute in the gym. Isolation work (bicep curls, leg extensions) can be reduced if time or energy is limited.
Time your training relative to meals. If possible, train 1-2 hours after a protein-rich meal when energy availability is highest. Some men find that training on injection day increases nausea — if that's you, schedule gym sessions for days 2-6 after your weekly injection.
The NEAT Solution
If the 560-step decline concerns you, the fix is conscious: set a daily step target (8,000-10,000 is reasonable on GLP-1 therapy) and track it. Walking meetings, evening family walks, parking further from stores, and taking stairs instead of elevators compensate for the unconscious activity decline without requiring additional gym time.
Sources
- ENDO 2026 — Fitbit data study on GLP-1 users and daily activity levels
- Pharmaceuticals (June 2026) — Resistance training and muscle preservation during GLP-1 therapy
- International Journal of Obesity (April 2026) — Body composition changes during GLP-1 treatment
Bodybuilding.com GLP-1
Custom pricing
Paid link · Affiliate disclosure